Lan et al. (2018) reported that the expression of PD-L1 is significantly correlated with KRAS gene mutations. Pan et al. (2021) reported that the expression of PD-L1 was higher in patients with NSCLC with KRAS G12V mutation than in patients with wild-type KRAS. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.